In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Emergent Biosolutions Inc (NYSE: EBS) closed at $10.89 in the last session, down -9.02% from day before closing price of $11.97. In other words, the price has decreased by -$9.02 from its previous closing price. On the day, 1.98 million shares were traded. EBS stock price reached its highest trading level at $11.65 during the session, while it also had its lowest trading level at $10.6334.
Ratios:
We take a closer look at EBS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.27. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On March 07, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeGolyer Donald W bought 25,000 shares for $11.77 per share.
White Marvin L bought 14,287 shares of EBS for $168,158 on Nov 11 ’24. On Jun 04 ’24, another insider, Zoon Kathryn C, who serves as the Director of the company, sold 10,000 shares for $6.11 each. As a result, the insider received 61,100 and left with 54,482 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 590065984 and an Enterprise Value of 1116165760. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 0.992 whereas that against EBITDA is -232.535.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 27.01%, while the 200-Day Moving Average is calculated to be 75.19%.
Shares Statistics:
According to the various share statistics, EBS traded on average about 2.41M shares per day over the past 3-months and 1799040 shares per day over the past 10 days. A total of 52.20M shares are outstanding, with a floating share count of 52.06M. Insiders hold about 3.91% of the company’s shares, while institutions hold 54.62% stake in the company. Shares short for EBS as of 1728950400 were 7791409 with a Short Ratio of 2.88, compared to 1726185600 on 4469735. Therefore, it implies a Short% of Shares Outstanding of 7791409 and a Short% of Float of 17.989999.
